Moreover, metabolomics studies of PD patient urine and cerebrospinal fluid have shown elevated levels of BCAAs23 and altered TCA cycle metabolites24, respectively, consistent with our findings in the bcat-1(RNAi) C. elegans model6. This evidence concerns the gene BCAT1 and Parkinson disease.